🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"We needed something outside the box…The other option was to take her home to hospice an enjoy the days you have left. I think most parents would take the leap that we did.” — Tom Whitehead on trying a then-experimental cancer therapy for his daughter, Emily #STATBreakthrough

#STATBreakthrough Tom Whitehead Emily Whitehead Foundation

The 2014 Matthew Herper story in Forbes on Emily Whitehead and CAR T Cell #immunotherapy is here: forbes.com/sites/matthewh…

At six years old, Emily Whitehead became the first child to receive CAR-T cancer therapy. Now 18, she spoke at #STATBreakthrough about being the face of a cure. trib.al/Gr7QlCt

CAR-T patient pioneer Emily Whitehead is ready for a new identity ⁦Jason Mast⁩ writes about ⁦Emily Whitehead Foundation⁩ at #STATBreakthrough. statnews.com/2023/05/03/emi…

Watch this exclusive clip from our Living With a Cure panel. With Matthew Herper, Emily Whitehead Foundation, and Tom Whitehead #STATBreakthrough

Team EWF is ready to get active to #ActivateTheCure at the Pittsburgh Marathon this weekend! Help us cheer on our runners by donating to support their overall fundraising goal: raceroster.com/events/2023/62…

This #MEDALMONDAY 🏅 we are celebrating our 2023 Pittsburgh Marathon Team EWF runners! Thank you for getting active with us this weekend to #activatethecure for childhood cancer. Ps. It’s not too late to support our runners overall fundraising goal! bit.ly/ewf-pgh23

An encore annual picture🙏 Emily Whitehead 11 years on & celebrating a cure! This is why we do what we do #CARTCell #tcellrx #immunotherapy #celltherapy #genetherapy #writeabetterstory Children's Hospital Penn Medicine Penn Medicine - Abramson Cancer Center Emily Whitehead Foundation emilywhiteheadfoundation.org

Today, Emily is 11 years cancer free! In Emily’s own words: “While this will be the last official cancer free pic, it certainly won’t be the end of me making the most of my life without cancer.” bit.ly/ewf-11yrs #WeBelieve #ActivateTheCure

As an organization founded in Philipsburg, PA we so proud to participate in #CentreGives! By donating during this 36-hour giving event, you can help us support families fighting cancer in our local area. Learn more: emilywhiteheadfoundation.org/events/centre-… Give now: centregives.org/organizations/…

Our 9th annual #TeeOff4TCells golf tournament is returning to Philipsburg Elks Lodge & Country Club on Friday, July 14. Limited tee times are available! Register now to secure your team's place: emilywhiteheadfoundation.org/golf/

Emily recently celebrated her 18th birthday, a milestone that seemed impossible when she was diagnosed with cancer at age 5. After treatments failed twice, a groundbreaking therapy was found. Join her journey and discover how Emily Whitehead Foundation is supporting other cancer patients.

Wishing you all a festive Independence Day filled with food, family, friends and fun!

Help support pediatric cancer immunotherapy research by becoming a sponsor for our Tee Off for T-cells golf fundraiser being held July 14! Your support will help fund innovative cancer research to save children’s lives. #ActivateTheCure Sponsorship info at emilywhiteheadfoundation.org/golf/

What a great day of golf and fundraising to #ActivateTheCure! Thanks to everyone who participated, sponsored and supported our 9th annual Tee Off for T-Cells golf tournament! We raised $40,000+ bringing our 9-year total to $450,000. We look forward to reaching $500,000 next year!

Exciting news! Kite, a Gilead Company, announced the first treatment in nearly 30 years to demonstrate a significant improvement in survival patients with relapsed or refractory large B-cell lymphoma bit.ly/3QQizbb

🚨NEW Commentary on #FDA 11/28/23 announcement "Unanswered questions following reports of secondary malignancies after CAR-T cell therapy" Nature Medicine - A consensus commentary from @ISCTGlobal ASTCT The EBMT CIBMTR Parker Institute for Cancer Immunotherapy Marcelo Pasquini John Connolly David Porter